Keywords: generex, sees, success, oral, insulin, biotechnology, revealed
Generex Sees Success With Oral Insulin
Article | 03 June 1999
Generex Biotechnology has revealed that Oralin/Oralgen, its oralliquid formulation of insulin, controls post-prandial hyperglycemia in a comparable manner to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
